CTOs on the Move

Tearlab

www.tearlab.com

 
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tearlab.com
  • 9980 Huennekens St. Ste 100
    San Diego, CA USA 92121
  • Phone: 855.832.7522

Executives

Name Title Contact Details

Similar Companies

Genicon

Genicon is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sensivida

"SensiVida Medical Technologies, Inc. is a minimally invasive Diagnostic Device company. Our patented Microsystems-based optical technology automates bio-sensing and data acquisition while minimizing patient discomfort. Our ""platform"" technology can be applied to a number of disease state diagnostics, including allergy testing, pain-free automated glucose monitoring and blood coagulation testing (e.g. for Coumadin patients), TB testing, and cholesterol monitoring."

Anspach Holdings

The Anspach Effort, Inc. is a successful, continuously evolving business whose focus concentrates on high-speed instrumentation for Neurosurgery, Neurotology, Otology, and Orthopedics. The company is committed to providing product quality, technology,

Protexx Dental/Medical Supplies

Protexx Dental/Medical Supplies is a Sudbury, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediBeacon

MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.